Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review
نویسندگان
چکیده
The death rate among chronic kidney disease patients is the highest compared to other chronic diseases. 60% of these fatalities are cardiovascular. Cardiovascular calcifications and chronic inflammation affect almost all chronic kidney disease patients and are associated with cardiovascular mortality. Fibroblast growth factor 23 is associated with vascular calcification. Systemic inflammation in chronic kidney disease patients is multifactorial. The role of systemic inflammation in the pathogenesis of vascular calcification was recently reappraised. Fibroblast growth factor 23 was accused as a direct stimulus of left ventricular hypertrophy, uremic inflammation, and impaired neutrophil function. This review will discuss the underlying mechanisms that underlie the link between Fibroblast growth factor 23 and increased mortality encountered among chronic kidney disease patients.
منابع مشابه
Nutritional Status of Patients with Chronic Kidney Disease in Iran: A Narrative Review
Background: Chronic kidney disease (CKD) is a progressive condition that affects many aspects of patient’s life with adverse outcomes of kidney failure, cardiovascular disease (CVD), and premature death. Malnutrition is a relatively common problem in these patients that may be the result of inadequate intake, increased catabolism, or loss of nutrients in the dialysis. The aim of this study was ...
متن کاملNon-albuminuric Diabetic Kidney Disease in Diabetic Patients: A Review
Introduction: The constantly increasing incidence of type 2 diabetes, probably due to obesity and sedentary life, has led to the increased incidence of macro- and microvascular diabetic complications such as nephropathy. Despite the prompt efforts to develop effective treatments for diabetes and slow the progression of its complications, it is still reported as the most common cause of chronic ...
متن کاملFibroblast growth factor: will this hormone be the hemoglobin A1c for managing phosphorus balance in chronic kidney disease?
Fibroblast growth factor 23 (FGF23) is a bone-derived hormone that regulates phosphorus and vitamin D metabolism by increasing the rate of urinary excretion of phosphate and by inhibiting the renal production of 1,25-dihydroxyvitamin D.1 In patients with chronic kidney disease (CKD), circulating FGF23 levels rise progressively as a physiological adaption to compensate for persistent phosphate r...
متن کاملCan Fibroblast Growth Factor-23 Improve Prognostication in Heart Failure Patients?
Fibroblast growth factor-23 (FGF-23) is a phosphate regulatory 251-aminoacid hormone secreted by osteocytes and acts as regulator phosphorus reabsorption in the proximal tubule of nephron and 1,25-dihydroxyvitamin D synthesis. Recent clinical studies have shown that higher serum FGF-23 levels are associated with subclinical cardiovascular (CV) disease, with new Heart Failure (HF) and chronic ki...
متن کاملFibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.
CONTEXT A high level of the phosphate-regulating hormone fibroblast growth factor 23 (FGF-23) is associated with mortality in patients with end-stage renal disease, but little is known about its relationship with adverse outcomes in the much larger population of patients with earlier stages of chronic kidney disease. OBJECTIVE To evaluate FGF-23 as a risk factor for adverse outcomes in patien...
متن کامل